1/ Our new perspective piece on “Crossreactive memory T cells and herd immunity to SARS-CoV-2”is out now.
@mlipsitch @yonatan @SetteLab @ljiresearch @NatRevImmunol

nature.com/articles/s4157… Image
2/ Given the amount of discussion in scientific, public, and political spheres, it is useful to undertake a thought experiment examining crossreactive T cell effects on COVID-19 disease severity and herd immunity, should crossreactive memory T cells confer some form of protection
3/ We consider immunological and epidemiological aspects and implications of pre-existing crossreactive immune memory to SARS-CoV-2, largely originating from previous exposure to circulating common cold coronaviruses.
4/ We propose four immunological scenarios for the impact of crossreactive CD4+ memory T cells on COVID-19 severity and viral transmission. For each scenario, we discuss implications for herd immunity and projections of the global impact of SARS2.
5/ In sum, we argue potential impacts of crossreactive T cell memory are already ‘baked in’ to epidemiological models, particularly regarding herd immunity.
6/ The implications of immunological processes on other aspects of SARS2 epidemiology are worthy of future study, and discussed in the paper.
7/ We emphasize that any functional role for crossreactive T cell memory in COVID-19 remains unproven, but the thought experiment is helpful.

nature.com/articles/s4157…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Shane Crotty

Shane Crotty Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @profshanecrotty

24 Sep
1/ There are several major aspects of what Scott Atlas is saying that are wrong.
2) There is no direct evidence that pre-existing T cell immunity affects COVID-19 infections. LJI researchers and other have proven that such T cells exist, but neither we nor anyone else have shown that the pre-existing T cells make COVID-19 better, worse, or no difference.
3) To say it another way, There is no direct evidence that crossreactive memory T cells to common cold viruses affects COVID-19.
Read 8 tweets
21 Sep
Crotty lab member of the week is Carolyn Rydyznski Moderbacher, PhD!
1. Carolyn is the lead author of our new COVID-19 immunology paper studying T cell and antibody responses in acute COVID-19 cases.
cell.com/cell/fulltext/…
@ljiresearch Image
2. Carolyn wasn’t planning on working on COVID-19, but she had developed excellent multi parameter flow cytometry panels for other human T cell studies, and AIM assays, and I needed her to take the lead on COVID-19 T cell work,
3. so she dropped her other project and has worked full time on COVID-19 for the past 6 months, trying to understand immunity to COVID-19. Culminating in the new paper. Image
Read 5 tweets
16 Sep
1/ Our newest COVID-19 immunology work is online today at Cell! @ljiresearch cell.com/cell/fulltext/…
2/ We aimed to better understand hospitalized COVID-19 cases by examining virus-specific immune responses all in the same people. SARS2-specific Helper T cells, killer T cells, and neutralizing antibodies.
3/ (I.e., measure the adaptive immune response in acute COVID-19 cases with virus-specific tools.)
Read 11 tweets
16 Sep
Our newest COVID-19 immunology work is online today at Cell! bit.ly/3mugShW
We aimed to better understand hospitalized COVID-19 cases by examining virus-specific immune responses all in the same people. SARS2-specific Helper T cells, killer T cells, and neutralizing antibodies.
(I.e., measure the adaptive immune response in acute COVID-19 cases with virus-specific tools.)
Read 10 tweets
8 Sep
1/ Crotty Lab member of the week: Yu (Alex) Kato
Alex led the work just published in @ImmunityCP on the multifaceted ways antigen valency affects B cell responses in vivo. That study is important for vaccine immunology, connecting vaccine designs to immunological rules. Image
2/ He used two photo intravital microscopy, custom engineered proteins, a variety of in vivo models manipulating antigen-specific B cells and CD4 T cells, and all kinds of flow cytometry to figure out this interesting and important puzzle. All told, it was almost 4 years of work!
3/ Alex has also been deeply involved in fantastically successful collaborations with Darrell Irvine's lab at MIT, including a novel vaccine delivery / adjuvant study in @NatureMedicine this year.
Read 4 tweets
31 Aug
1/ Our new paper is out: Multifaceted Effects of Antigen Valency on B Cell Responses In Vivo.
bit.ly/34MMKrJ
There is lots of excitement about nanoparticle vaccine designs, and a general consensus that multivalency is a good thing for vaccines. @ljiresearch @ImmunityCP Image
2/ But, mechanistic immunological understand of the impact of valency has been limited, for a variety of reasons. Here, we completed a four years study of valency and and affinity on antigen-specific B cell responses in vivo.
3/ We found that antigen valency dictates the magnitude and composition of B cell responses. Antigen valency alters breadth of B cell affinities recruited. And valency appears to modulate both the magnitude and the clonal compositions of GC responses.
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!